XML 63 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1
Investments in and Advances to Unconsolidated Joint Ventures - Equity Method Investments (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
item
Dec. 31, 2016
USD ($)
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 827,202 $ 571,491
CCRC JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Number of unconsolidated joint ventures | item 2  
CCRC JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 434,649 439,449
Investment ownership percentage 49.00%  
RIDEA II | SHOP    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 263,180  
Investment ownership percentage 40.00%  
MBK JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 39,088 38,909
Investment ownership percentage 50.00%  
MBK Development JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 2,464 2,463
Investment ownership percentage 50.00%  
MBK JV and MBK Development JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Number of unconsolidated joint ventures | item 2  
HCP Ventures IV, LLC | Medical office    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 7,338 7,277
Investment ownership percentage 20.00%  
HCP Life Science | Life science    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 65,490 67,879
Number of unconsolidated joint ventures | item 3  
HCP Life Science | Life science | Minimum    
Company owned interests in entities, accounted under equity method:    
Investment ownership percentage 50.00%  
HCP Life Science | Life science | Maximum    
Company owned interests in entities, accounted under equity method:    
Investment ownership percentage 63.00%  
Torrey Pines Science Center, LP | Life science    
Company owned interests in entities, accounted under equity method:    
Investment ownership percentage 50.00%  
Britannia Biotech Gateway, LP | Life science    
Company owned interests in entities, accounted under equity method:    
Investment ownership percentage 55.00%  
LASDK, LP | Life science    
Company owned interests in entities, accounted under equity method:    
Investment ownership percentage 63.00%  
Vintage Park Development JV | SHOP    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 6,953 7,486
Investment ownership percentage 85.00%  
Suburban Properties, LLC | Medical office    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 4,618 4,628
Investment ownership percentage 67.00%  
K&Y    
Company owned interests in entities, accounted under equity method:    
Number of unconsolidated joint ventures | item 3  
K&Y | Other Non-reportable segments    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 1,380 1,342
Investment ownership percentage 80.00%  
Advances to unconsolidated joint ventures, net    
Company owned interests in entities, accounted under equity method:    
Investments in and advances to unconsolidated joint ventures $ 2,042 $ 2,058